STAND. COM. REP. NO. 1454-18

Honolulu, Hawaii

, 2018

RE: S.B. No. 2646

S.D. 1

H.D. 2

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sir:

Your Committee on Consumer Protection & Commerce, to which was referred S.B. No. 2646, S.D. 1, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"

begs leave to report as follows:

The purpose of this measure is to reduce the public's access to Schedule II, III, or IV controlled substances by:

(1) Requiring a prescriber to consult the States Electronic Prescription Accountability System before writing a prescription for the controlled substance in a quantity equaling a supply of seven days or longer; and

(2) Specifying that a prescriber's failure to consult the Electronic Prescription Accountability System under certain conditions may result in professional discipline of the prescriber.

The Department of Public Safety, Department of Health, Oahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i, and Hawaii Medical Service Association provided testimony in support of this measure. The American Society of Clinical Oncology, Hawaii Society of Clinical Oncology, Hawaii Society of Pain Physicians, and Hawaii Substance Abuse Coalition provided comments on this measure.

Your Committee has amended this measure by:

(1) Exempting for prescriptions for continuous or prolonged treatment of a patient; provided that the prescriber consults the Electronic Prescription Accountability System at least once every six months; and

(2) Authorizing a requesting prescriber's delegate to receive requested records.

As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2646, S.D. 1, H.D. 1, as amended herein, and recommends that it be referred to your Committee on Judiciary in the form attached hereto as S.B. No. 2646, S.D. 1, H.D. 2.

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

____________________________

ROY M. TAKUMI, Chair